HCM
HUTCHMED (China) Limited
NASDAQHealthcareDrug Manufacturers - Specialty & GenericHK
Rating:C-
Company Profile
CEO
Chig Fung Cheng
IPO Date
2016-03-16
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
HK
HUTCHMED (China) Limited
CEO
Chig Fung Cheng
IPO Date
2016-03-16
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
HK
| 26,307 |
| $0.00 |
| 21 May 2026 | Nixon Charles George Rupert | Group General Counsel | J-Other | Acquired | 7,445 | $0.00 |
| 21 May 2026 | Nixon Charles George Rupert | Group General Counsel | J-Other | Acquired | 7,644 | $0.00 |
| 21 May 2026 | Su Wei-guo | director, officer: CEO and CSO | J-Other | Acquired | 132,864 | $0.00 |
| 21 May 2026 | Su Wei-guo | director, officer: CEO and CSO | J-Other | Acquired | 75,140 | $0.00 |
| 21 May 2026 | Chiu Lorenso | Deputy Chief Financial Officer | J-Other | Acquired | 5,176 | $0.00 |
| 21 May 2026 | Chiu Lorenso | Deputy Chief Financial Officer | J-Other | Acquired | 8,863 | $0.00 |
| 13 May 2026 | Mok Tony Shu Kam | — | Disposed | 0 | $0.00 |
| 31 Mar 2026 | Nixon Charles George Rupert | Group General Counsel | Disposed | 0 | $0.00 |